Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction

Growth Hormone and IGF Research

Volumn 19, Issue 3, 2009, Pages 252-255

  Akin, Fulya ^a   Yaylali, Guzin Fidan ^a   Turgut, Sebahat ^a   Kaptanoglu, Bunyamin ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

GH IGF I axis; IGFBP 3; Subclinical hyperthyroidism; Subclinical hypothyroidism

Indexed keywords

GROWTH HORMONE; INSULIN; LEVOTHYROXINE; LIOTHYRONINE; PROPRANOLOL; PROPYLTHIOURACIL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROID HORMONE; THYROTROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; THYROTROPIN; THYROXINE;

EID: 67349225403     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.11.003     Document Type: Article

References (27)

1. Laron Z. Interactions between the thyroid hormones and the hormones of the growth hormone axis. Pediatr. Endocrinol. Rev. 2 (2003) 244-249
2. Wolf M., Ingbar S.H., and Moses A.C. Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat. Endocrinology 125 (1989) 2905-2914
3. Torre G., Barreca A., Borgonovo G., Minuto M., Ansaldo G.L., Varaldo E., and Minuto F. Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127 (2000) 99-103
4. Hussain M.A., Schmitz O., Jorgensen J.O.L., Christiansen J., Weeke J., Schmid Ch., and Froesch E.R. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Eur. J. Endocrinol. 134 (1996) 563-567
5. Jørgensen J.O., Ovesen P., Juul A., Hansen T.K., Skakkebaek N.E., and Christiansen J.S. Impact of growth hormone administration on other hormones. Horm. Res. 51 (1999) 121-126
6. Jorgensen J.O., Pedersen S.A., Laurberg P., Weeke J., Skakkebaek N.E., and Christiansen J.S. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J. Clin. Endocrinol. Metab. 69 (1989) 1127-1132
7. Miyakawa M., Saji M., Tsushima T., Wakai K., and Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J. Clin. Endocrinol. Metab. 67 (1988) 973-978
8. Miell J.P., Taylor A.M., Zini M., Maheshwari H.G., Ross R.J.M., and Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J. Clin. Endocrinol. Metab. 76 (1993) 950-955
9. Miell J.P., Zini M., Quin J.D., Jones J., Portioli I., and Valcavi R. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy. J. Clin. Endocrinol. Metab. 79 (1994) 1507-1512
10. Angervo M., Toivonen J., Leinonen P., Valimaki M., and Seppala M. Thyroxine withdrawal is accompanied by decreased circulating levels of insulin-like growth factor-binding protein-1 in thyroidectomized patients. J. Clin. Endocrinol. Metab. 76 (1993) 1199-1201
11. Angervo M., Tiihonen M., Leinonen P., Valimaki M., and Seppala M. Thyroxine treatment increases circulating levels of insulin-like growth factor binding protein-1: a placebo-controlled study. Clin. Endocrinol. 38 (1993) 547-551
12. Inukai T., Takanashi K., Takebayashi K., Fujiwara Y., Tayama K., and Takemura Y. Thyroid hormone modulates insulinlike growth factor-I (IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases. Horm. Metab. Res. 31 (1999) 576-579
13. Nazaimoon W.M.W., and Khalid B.A.K. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH suppressed Graves' disease. Horm. Metab. Res. 30 (1998) 213-216
14. Cassio A., Cacciari E., Balsamo A., Colli C., Pasini A., Salvioli G.P., Lanari M., Lasio R., Boschi S., and Pirazzoli P. Low growth hormone-binding protein in infants with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 83 (1998) 3643-3646
15. Lakatos P., Foldes J., Nagy Z., Takacs I., Speer G., Horvath C., Mohan S., Baylink D.J., and Stern P.H. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. Thyroid 10 (2000) 417-423
16. Jenkins R.C., Valcavi R., Zini M., Frasoldati A., Heller S.R., Camacho-Hubner C., Gibson J.M., Westwood M., and Ross R.J.M. Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism. Clin. Endocrinol. 52 (2000) 187-195
17. Angervo M., Leinonen P., Koistinen R., Julkunen M., and Seppala M. Triiodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells. J. Mol. Endocrinol. 10 (1993) 7-13
18. Valcavi R., Dieguez C., Zini M., Muruais C., Casanueva F., and Portioli I. Influence of hyperthyroidism on growth hormone secretion. Clin. Endocrinol. 38 (1993) 515-522
19. Toft A.D. Clinical practice. Subclinical hyperthyroidism. New Engl. J. Med. 345 (2001) 512-516 Review
20. Singh S., Duggal J., Molnar J., Maldonado F., Barsano C.P., and Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int. J. Cardiol. 125 (2008) 41-48
21. Akin F., Bastemi{dotless}r M., Yaylali G.F., Alkis E., and Kaptanoglu B. Growth hormone/insulin like growth factor axis in patients with subclinical hypothyroidism. Clin. Endocrinol. (Oxford) 68 (2008) 1009-1010
22. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., Franklyn J.A., Hershman J.M., Burman K.D., Denke M.A., Gorman C., Cooper R.S., and Weissman N.J. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
23. Valcavi R., Dieguez C., Preece M., Taylor A., Portioli I., and Scanlon M.F. Effect of thyroxine replacement therapy on plasma insulin like growth factor I levels and growth hormone responsiveness to growth hormone releasing hormone in hypothyroid patients. Clin. Endocrinol. 27 (1987) 85-90
24. Iglesias P., Bayón C., Méndez J., González Gancedo P., Grande C., and Díez J.J. Serum insulin-like growth factor type1, insulin like growth factor binding protein-1 and, insulin like growth factor binding protein-3 concentrations in patients with thyroid dysfunction. Thyroid 11 (2001) 1043-1048
25. Valcavi R., Zini M., and Portioli I. Thyroid hormones and growth hormone secretion. J. Endocrinol. Invest. 15 (1992) 313-330
26. De Bellis A., Bizzarro A., Conte M., Perrino S., Coronella C., Solimeno S., Sinisi A.M., Stile L.A., Pisano G., and Bellastella A. Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J. Clin. Endocrinol. Metab. 88 (2003) 650-654
27. Zimmermann-Belsing T., Juul A., Juul Holst J., and Feldt-Rasmussen U. The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment. Growth. Horm. IGF Res. 14 (2004) 235-244